Please login to the form below

Not currently logged in
Email:
Password:

Sage

This page shows the latest Sage news and features for those working in and with pharma, biotech and healthcare.

Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3

Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3

Biogen and Sage signed a $3.1bn deal last year to jointly develop potential depression therapies. ... In November 2020, Biogen signed a $3.1bn deal focused on a series of potential depression and movement disorder therapies under development by Sage.

Latest news

More from news
Approximately 9 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • How will COVID-19 affect uptake of vaccinations against other diseases? How will COVID-19 affect uptake of vaccinations against other diseases?

    Interim guidance published by the WHO Strategic Advisory Group of Experts (SAGE) on 21 September suggests that there is a need to reconsider the prioritisation of risk groups for influenza vaccination

  • How merging firms can manage culture change How merging firms can manage culture change

    Globally, we've seen a deal struck between US firms Abbott and Alere for $5.8bn, while on the same day Stryker agreed to buy Sage for around $2.8bn.

  • Deal Watch February 2016 Deal Watch February 2016

    Turning to medtech, Stryker has had a busy month acquiring two companies, Sage Products and Physio-Control, paying over $4bn in cash for the two transactions. ... acquisition - company. 5, 800. Sage Products/ Stryker Corporation. portfolio of disposable

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Horizon Discovery appoints executive director Horizon Discovery appoints executive director

    Smoller joined Horizon as chief business officer as part of the form's acquisition of Sage Labs for $48m in September this year. ... company.”. His previous roles include the position of CEO at Sage Labs, chief scientific officer of Sigma-Aldrich and

  • Evoke Pharma adds to executive team Evoke Pharma adds to executive team

    Dr Alves joins from Sage Clinical Development where he served as president and principal consultant.

  • Blue Latitude boosts senior management team Blue Latitude boosts senior management team

    During her time as director of del Galdo Consulting, del Galdo worked with GSK &Ogilvy Common Health, Freesat, Thomson Reuters, Human Factors International, HomeAway, Sage, and Further on a variety of

  • Shires's Jeffrey Jonas to lead Sage Shires's Jeffrey Jonas to lead Sage

    CNS appoints CEO alongside new CMO and CFO. Sage Therapeutics has made several changes at the top level, including the appointment of Shire's Dr Jeffrey Jonas as CEO. ... The changes come two years after the formation of the central nervous system (CNS)

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...